Skip to main content
Normal View

Tuesday, 27 Feb 2024

Written Answers Nos. 493-512

Health Service Executive

Questions (493)

Louise O'Reilly

Question:

493. Deputy Louise O'Reilly asked the Minister for Health if he is aware that residents living in HSE-owned properties at a location (details supplied) cannot access grants or any other supports for insulation or upgrading their homes; if he is aware that the residents are living in houses that are in an extremely poor state of repair but cannot get their landlord (the HSE) to carry out any necessary internal repairs; if he plans to support the residents or to arrange for the repairs to be carried out; and if he will make a statement on the matter. [8715/24]

View answer
Awaiting reply from Department.

Hospital Appointments Status

Questions (494)

Michael Healy-Rae

Question:

494. Deputy Michael Healy-Rae asked the Minister for Health the status of a hospital appointment for a person (details supplied); what options are available to them; and if he will make a statement on the matter. [8717/24]

View answer
Awaiting reply from Department.

Hospital Appointments Status

Questions (495)

Michael Healy-Rae

Question:

495. Deputy Michael Healy-Rae asked the Minister for Health the status of a hospital appointment for a person (details supplied); and if he will make a statement on the matter. [8720/24]

View answer
Awaiting reply from Department.

Medicinal Products

Questions (496)

Jackie Cahill

Question:

496. Deputy Jackie Cahill asked the Minister for Health if romosozumab, which is used to treat women with severe osteoporosis, is also approved by the EMT for use in Ireland for men with severe osteoporosis (details supplied); if romosozumab is approved by the EMT to be used under medical supervision by a registered consultant in Ireland for a 45-year-old male with severe osteoporosis with a very high risk of bone fracture; and if he will make a statement on the matter. [8732/24]

View answer
Awaiting reply from Department.

Health Services

Questions (497)

Mairéad Farrell

Question:

497. Deputy Mairéad Farrell asked the Minister for Health the practices of the national gender service that consultants are concerned would be affected by a potential ban on conversion therapy, as referenced in a newspaper article (details supplied) in June 2023. [8744/24]

View answer
Awaiting reply from Department.

Health Services

Questions (498)

Mairéad Farrell

Question:

498. Deputy Mairéad Farrell asked the Minister for Health the reason the national gender service believes a conversion therapy ban would make it impossible to develop a children's service as referenced in a newspaper article (details supplied) in December 2023. [8745/24]

View answer
Awaiting reply from Department.

Ambulance Service

Questions (499)

Ivana Bacik

Question:

499. Deputy Ivana Bacik asked the Minister for Health his plans to reduce waiting times for ambulance arrival; and if he will supply a breakdown of average wait times in each county. [8752/24]

View answer

Written answers

As this is a service matter I have asked the Health Service Executive (HSE) to respond to the Deputy directly, as soon as possible.

Prescription Charges

Questions (500)

Ivana Bacik

Question:

500. Deputy Ivana Bacik asked the Minister for Health his plans to remove prescription fees for medical cardholders. [8757/24]

View answer
Awaiting reply from Department.

Mental Health Commission

Questions (501)

Willie O'Dea

Question:

501. Deputy Willie O'Dea asked the Minister for Health if he will consider the regulation of CAMHS, which would ensure that recommendations on governance and clinical reform made by the Mental Health Commission can be implemented by the HSE and the State; if he will allow the Mental Health Commission to monitor the implementation of any such recommendations and allow it to publish an annual report on progress; and if he will make a statement on the matter. [8759/24]

View answer

Written answers

Of the 49 recommendations made by the Mental Health Commission in their Child and Adolescent Mental Health Service (CAMHS) report, the HSE have reported that approximately 40 of the 45 recommendations that fall under their remit are in progress. A number of these recommendations also relate to new service developments which are dependent on further investment.

Responsibility for 4 recommendations lie with the Department of Health.

Recommendation one, made by the Mental Health Commission, recommends the immediate and independent regulation of CAMHS by the Mental Health Commission, and that regulation must be put in place to ensure that all children have access to evidence-based and safe services, regardless of geographical location or ability to pay. The Government recognises the importance of ensuring all mental health services, both inpatient and community, and both adult and child and adolescent, are fully registered, regulated, and inspected by the Mental Health Commission in its role as the independent regulator of mental health services.

Under the Mental Health Act 2001, the Mental Health Commission registers, inspects, and regulates all inpatient mental health services, including inpatient CAMHS. The current Mental Health Act 2001 does not include any provisions for the registration or regulation of community mental health services and therefore, it is not considered that the Act provides the necessary legal basis to expand the Commission’s regulatory remit.

The expansion of the Mental Health Commission’s role into regulating all community mental health services, including community CAMHS, is being addressed in the forthcoming Mental Health Bill. This new Bill is a complex and lengthy piece of legislation. It will provide the necessary legal underpinning to ensure that the Mental Health Commission can regulate all community services. Additionally, the Bill will overhaul the involuntary admission and detention process, modernise provisions related to consent to treatment, provide enhanced safeguards for people accessing inpatient treatment, and provide a new, discrete Part that relates exclusively to the care and treatment of children and young people.

Drafting of this Bill has been prioritised and it is now in its final months of drafting. It will be introduced to the Oireachtas in the summer legislative session, which begins in April.

Recommendation 2 relates to the implementation of these recommendations must be monitored by the Mental Health Commission who must publish a yearly report on progress of implementation.

My Department recognises that the Mental Health Commission play a vital role in the independent monitoring of mental health services in Ireland. The Department of Health welcomes the Commission’s focus on service improvement in CAMH services, particularly on foot of this report, however it is the role of the Department of Health to ensure that key performance metrics for HSE services are met, that investment is used for agreed service developments, and that policy recommendations are reviewed and enacted as appropriate. The functions of the Commission, as set out in section 33 of the Mental Health Act, do not include a function to oversee or monitor the performance of the HSE outside of services registered as approved centres nor do they grant an implementation function on the Commission. It is for the Minister and Department to either accept or not accept the recommendations arising from the Inspector’s report and for the Minister and Department to set any targets or goals for the implementation of any such recommendations, in consultation with the HSE and the Commission as appropriate.

The Department of Health has a key role in policy development, service development, and performance management. Officials in the Department of Health meet with senior HSE executives every month in the context of performance monitoring. A standing item on the performance agenda is child and adolescent mental health services (CAMHS), as well as progression and publication of the HSE audits arising from the Maskey Report. The Department have reviewed the 49 recommendations and in collaboration with the HSE continue to progress the recommendations from this report as part of engagements and performance meetings as deemed appropriate.

Legislative Process

Questions (502)

Michael Ring

Question:

502. Deputy Michael Ring asked the Minister for Health if proposed amendments (details supplied) will come before Dáil Éireann; and if he will make a statement on the matter. [8761/24]

View answer
Awaiting reply from Department.

Covid-19 Pandemic Supports

Questions (503)

Steven Matthews

Question:

503. Deputy Steven Matthews asked the Minister for Health the position regarding special leave with pay for front-line healthcare workers who are suffering with long Covid; if a further extension or an alternative support scheme is being considered for those in this situation; and if he will make a statement on the matter. [8766/24]

View answer
Awaiting reply from Department.

Healthcare Policy

Questions (504)

Kathleen Funchion

Question:

504. Deputy Kathleen Funchion asked the Minister for Health the status of an update for survivors of the vaginal mesh controversy; if a scheme or some level of assistance will be offered to women left in this situation; and if he will make a statement on the matter. [8771/24]

View answer
Awaiting reply from Department.

Mental Health Policy

Questions (505)

Richard Boyd Barrett

Question:

505. Deputy Richard Boyd Barrett asked the Minister for Health the reason the long-term illness scheme only includes mental health conditions for persons under 16 years of age; his plans to extend this beyond 16 years of age; and if he will make a statement on the matter. [8798/24]

View answer

Written answers

The Long-Term Illness (LTI) scheme was established under Section 59(3) of the Health Act 1970 (as amended). Regulations were made in 1971, 1973 and 1975, prescribing 16 illnesses covered by the scheme.

These are: acute leukaemia; mental handicap; cerebral palsy; mental illness (in a person under 16); cystic fibrosis; multiple sclerosis; diabetes insipidus; muscular dystrophies; diabetes mellitus; parkinsonism; epilepsy; phenylketonuria; haemophilia; spina bifida; hydrocephalus; and conditions arising from the use of Thalidomide.

Under the LTI Scheme, patients receive drugs, medicines, and medical and surgical appliances directly related to the treatment of their illness, free of charge.

Statutory Instrument No. 277 of 1971, put a limitation on Section 59(3) of the Health Act 1970, in respect of the provision of medicines to those suffering from mental illness:

 "Arrangements for the supply of drugs and medicines to persons suffering from mental illness in pursuance of section 59 (3) of the Act shall be made only in respect of persons under the age of 16 years."

Therefore, the limitation on age currently applies to persons eligible for the LTI Scheme under the category of "mental illness"; the Scheme has operated on this basis since its inception.

However, it is important to remember that the LTI Scheme exists within a wider eligibility framework. This Government has put a significant focus on improving access to and the affordability of healthcare services, advancing substantial policy, legislation and investment to deliver expanded eligibility in line with the vision, aims and objectives of Sláintecare.

In 2022, a range of measures were delivered including the abolition of public inpatient charges for children, reductions in the Drug Payment Scheme threshold to €80 per month, and the introduction of free contraception for women aged 17-25.

Additional measures in 2023 continued to expand eligibility. These included an expansion of GP care without charges to children aged 6 and 7, and to people earning no more than the median household income, the abolition of all public in-patient hospital charges for adults, and the extension of the free contraception scheme to include women aged 26-30. 

These measures continue to create a health and social care service that offers affordable access to quality healthcare.

People who cannot, without undue hardship, arrange for the provision of medical services for themselves and their dependants may be eligible for a medical card. In accordance with the provisions of the Health Act 1970 (as amended), eligibility for a medical card is determined by the HSE. Medical card eligibility is primarily based on an assessment of means and is not granted on the basis of any particular condition.

In certain circumstances the HSE may exercise discretion and grant a medical card, even though an applicant exceeds the income guidelines, where he or she faces difficult financial circumstances, such as extra costs arising from illness. In circumstances where an applicant is still over the income limit for a medical card, they are then assessed for a GP visit card, which entitles the applicant to GP visits without charge.

Under the Drug Payment Scheme (DPS), no individual or family pays more than €80 a month towards the cost of approved prescribed medicines. The DPS is not means tested and is available to anyone ordinarily resident in Ireland. The DPS significantly reduces the cost burden for families and individuals with ongoing expenditure on medicines.

Individuals may also be entitled to claim tax relief on the cost of their medical expenses, including medicines prescribed by a doctor, dentist, or consultant. Relief is at the standard tax rate of 20%.

Health Service Executive

Questions (506)

Ged Nash

Question:

506. Deputy Ged Nash asked the Minister for Health the way in which the HSE plans to award a tender for a service (details supplied); and if he will make a statement on the matter. [8803/24]

View answer
Awaiting reply from Department.

Hospital Admissions

Questions (507)

Colm Burke

Question:

507. Deputy Colm Burke asked the Minister for Health the total number of inpatients admitted to Bantry General Hospital in 2019, 2020, 2021, 2022 and 2023; the average length of stay for each patient, in tabular form; and if he will make a statement on the matter. [8806/24]

View answer

Written answers

In relation to the particular query raised, as this is a service matter I have asked the Health Service Executive to respond directly to the Deputy as soon as possible.

Hospital Admissions

Questions (508)

Colm Burke

Question:

508. Deputy Colm Burke asked the Minister for Health the total number of outpatients who attended Bantry General Hospital in 2019, 2020, 2021, 2022 and 2023, in tabular form; and if he will make a statement on the matter. [8807/24]

View answer

Written answers

In relation to the particular query raised, as this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Disabilities Assessments

Questions (509)

Paul Kehoe

Question:

509. Deputy Paul Kehoe asked the Minister for Health if plans are in place to expand the HSE national pilot for ADHD in adults, which is currently restricted to three CHOs, to provide access to assessments and therapies to adults throughout the country; and if he will make a statement on the matter. [8820/24]

View answer
Awaiting reply from Department.

Hospital Waiting Lists

Questions (510)

David Cullinane

Question:

510. Deputy David Cullinane asked the Minister for Health the number of patients removed from hospital waiting lists through validation processes for each year 2019 to 2023, by reason for removal, in tabular form. [8822/24]

View answer

Written answers

Periodic validation forms an essential part of best practice in relation to the management of hospital waiting lists. 

Validation is a process whereby hospital administration contacts patients on waiting lists at pre-planned intervals to ensure that patients are ready, willing, suitable and available to attend a hospital appointment or if they wish to be removed.

For a number of years validation was conducted at individual hospital level in Ireland but in 2018, the Minister for Health approved the establishment of the National Centralised Validation Unit (NCVU) within the National Treatment Purchase Fund (NTPF). The establishment of a centralised function has facilitated the introduction of a standardised approach to validation of waiting lists across all hospitals and across Inpatient Day Case and Outpatient waiting lists.

In relation to the data requested by the Deputy, the NCVU provided the figures in the following table relating to the total number of patients removed from hospital waiting lists each year from 2019 to 2023 as part of the NCVU validation programme. The NCVU has advised my Department that it is not possible to provide a breakdown of the reasons for removal.

-

National Waiting List Validation 2019 - 2023 Total Removals Summary by Year

2019

2020

2021

2022

2023

Total

52,921

32,879

80,728

120,547

129,473

416,548

Primary Medical Certificates

Questions (511)

Darren O'Rourke

Question:

511. Deputy Darren O'Rourke asked the Minister for Health further to Parliamentary Questions Nos. 84, 89, 94, 96, 113, 131 and 148 of 24 November 2023, regarding a case (details supplied) as it related to the primary medical certificate and the disabled drivers and passengers scheme, the alternative supports that are in place until the planned review takes place; and if he will make a statement on the matter. [8835/24]

View answer

Written answers

I wish to advise the Deputy that this is a matter for the Department of Finance.

Hospital Services

Questions (512)

Catherine Connolly

Question:

512. Deputy Catherine Connolly asked the Minister for Health the status of the expert review of the paediatric orthopaedic surgery service at CHI; the timeline for the completion of the review; if he has received any interim reports to date; if so, his plans for the publication of same; and if he will make a statement on the matter. [8844/24]

View answer

Written answers

While concluding this review in a timely manner is important for all concerned, the review by Mr Nayagam is entirely independent. Therefore, a timeline for completion and publication of the independent review cannot be confirmed at this stage of the process. Mr Nayagam has advised he deems it necessary to review cases from additional patient cohorts. This includes additional cases that have been identified as part of an internal clinical assurance process as potential “cases of concern”. These families have been informed. Other cases were selected at random by Mr Nayagam's Independent Review team. These families have also been informed. Advocacy Groups have been advised that the first phase of the review will now be delayed, as well as of the necessity to review cases from additional patient cohorts. This first phase of the independent review is now expected to be completed in April 2024, after which the timeline for completion of the review and publication of the final report will become clearer. The final report will be published, and it is essential that the recommendations and learnings from this review is adopted and fully implemented.

Top
Share